The purpose of this study is to examine the impact of daily consumption of walnuts for 12 weeks on cognitive function, markers of inflammation and oxidative stress, and the gut microbiome in healthy adults age 55 years and older.
The investigators will determine the extent to which daily consumption of walnuts by older adults for 12 weeks influences cognitive function and whether improvements are associated with changes in the resident gut microbiota. The investigators propose that age-related cognitive decline can be mitigated by consuming walnuts, by modulating the microbiota and microbial metabolites and decreasing oxidative stress and inflammation.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Enrollment
80
Oregon State University
Corvallis, Oregon, United States
RECRUITINGCognitive function - memory
Change from baseline at week 12: age adjusted standard scores (higher score reflects positive outcome)
Time frame: 0 and 12 weeks
Cognitive function - memory
Change from baseline at week 12: proximity (lower score reflects positive outcome)
Time frame: 0 and 12 weeks
Cognitive function - cognitive flexibility
Change from baseline at week 12: age adjusted standard scores (higher score reflects positive outcome)
Time frame: 0 and 12 weeks
Cognitive function - cognitive flexibility
Change from baseline at week 12: proximity (lower score reflects positive outcome)
Time frame: 0 and 12 weeks
Cognitive function - speed of processing
Change from baseline at week 12: age adjusted standard scores (higher score reflects positive outcome)
Time frame: 0 and 12 weeks
Gut microbiome composition
Change from baseline at week 12: microbiome composition
Time frame: 0 and 12 weeks
Lipid oxidation levels
Change from baseline at week 12: plasma malondialdehyde (MDA)
Time frame: 0 and 12 weeks
Gut permeability and health: Inflammatory biomarkers
Change from baseline at week 12: Gut inflammatory biomarkers fecal calprotectin and myeloperoxidase
Time frame: 0 and 12 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Biomarkers of inflammation
Change from baseline at week 12: Plasma inflammatory markers (ex. CRP and IL-6)
Time frame: 0 and 12 weeks
Urolithin concentrations
Change from baseline at week 12: urolithin A and urolithin B concentrations in urine
Time frame: 0 and 12 weeks
Blood pressure
Change from baseline at week 12: systolic and diastolic blood pressure
Time frame: 0 and 12 weeks
Weight
Change from baseline at week 12: weight
Time frame: 0 and 12 weeks